Arthritis Research UK Gout Treatment Trial - Phase 2

Last updated: January 4, 2017
Sponsor: University of Nottingham
Overall Status: Completed

Phase

N/A

Condition

Joint Injuries

Arthritis And Arthritic Pain (Pediatric)

Collagen Vascular Diseases

Treatment

N/A

Clinical Study ID

NCT01477346
11115
  • Ages > 21
  • All Genders

Study Summary

The purpose of this study is to determine in community-derived patients with gout the effectiveness, and cost effectiveness, of a nurse-led complex intervention that reflects recommended best practice (including patient information concerning gout, its prognosis and its non-pharmacological and drug options).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of gout

  • At least one acute attack of gout within previous 12 months

Exclusion

Exclusion Criteria:

  • Inability to give informed consent and known terminal or mental illness

Study Design

Total Participants: 517
Study Start date:
March 01, 2013
Estimated Completion Date:
October 31, 2016

Connect with a study center

  • Academic Rheumatology, University of Nottingham

    Nottingham, NG5 1PB
    United Kingdom

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.